RecruitingPhase 4NCT06433310
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
Sponsor
Weill Medical College of Cornell University
Enrollment
20 participants
Start Date
Oct 17, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to explore how the dietary supplement L-Phenylalanine affects the production of the metabolite phenylpropionic acid (PPA) and changes fungal populations of the gut microbiome.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Male or female adults over the age of 18 years
Exclusion Criteria6
- History of a diagnosis of any gastrointestinal condition, such as inflammatory bowel syndrome or disease
- Antibiotic usage within the past two weeks
- Antifungal usage within the past month
- Allergy to L-Phenylalanine or individuals with phenylketonuria (PKU)
- Adults taking medications known to interact with L-phenylalanine supplements, such as Monoamine Oxidase Inhibitors (MOAI), L-DOPA, and some antipsychotic drugs (complete and extensive drug list will be provided to interested participants during screening)
- Pregnant or nursing women
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGL-Phenylalanine 500 mg Veg Capsule product
500 mg Veg Capsule product
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06433310
Related Trials
Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis
NCT072251531 location
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
NCT067355991 location
Microbiome and Diet in Parkinson's Disease
NCT062071361 location
Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men
NCT074815781 location
Flourish: Exploring the Early Infant Gut Microbiome
NCT073334821 location